Selling Alogliptin

[Anonymous]

Canadian rep here.

What has been the experience to date in the US selling this product. We are getting it later this year and it looks like a "dog with fleas" I doubt we get more than 1% market share, if that! It quite possible that Takeda would make money not launching it.

 

[Anonymous]

Canadian rep here.

What has been the experience to date in the US selling this product. We are getting it later this year and it looks like a "dog with fleas" I doubt we get more than 1% market share, if that! It quite possible that Takeda would make money not launching it.

We will be launching it in June

 

[Anonymous]

We will be launching it in June

Yes, because it was only approved months ago and our company was not prepared enough to launch it immediately, even though we've had 4 years worth of delays to prepare for it.

Yet another great example of your Takeda leadership at your service

 

[Anonymous]

We will be launching it in June

Sure you will. Keep dreaming

 

[Anonymous]

Canadian rep here.

What has been the experience to date in the US selling this product. We are getting it later this year and it looks like a "dog with fleas" I doubt we get more than 1% market share, if that! It quite possible that Takeda would make money not launching it.

"Dog with fleas". Nice!

 

[Anonymous]

Yes, because it was only approved months ago and our company was not prepared enough to launch it immediately, even though we've had 4 years worth of delays to prepare for it.

Yet another great example of your Takeda leadership at your service

No they were waiting for the lawsuit to finalized before deciding if we are launching it or not. Looks like its a no go. DM meeting next week is when the ax will fall